The current study aimed to understand motivations of high-risk polysubstance use. Semi-structured interviews were conducted in New York City with 20 individuals with frequent recent polysubstance use. Two analysts coded the interviews (κ = 93.97). Five themes related to motivation for polysubstance use were found: (1) balance, prolong, or enhance effects, (2) self-medicate physical ailments, (3) cope with emotional distress, (4) drug-induced cravings, and (5) responding to social contexts. Individuals reported simultaneous or sequential co-use to balance, prolong or enhance a ‘high’ (theme 1). Participants engaged in polysubstance use to alleviate withdrawal symptoms, to induce sleep and self-medicate physical pain (theme 2) and to provide relief from emotional distress (theme 3). Other themes included drug-induced cravings (theme 4) and responding to social contexts (theme 5) including both social situations and economic availability. Motivations for polysubstance use may provide important insight into harm reduction and treatment settings solutions.
BartramM. (2021). ‘It’s really about wellbeing’: A Canadian investigation of harm reduction as a bridge between mental health and addiction recovery. International Journal of Mental Health and Addiction, 19(5), 1497–1510. https://doi.org/10.1007/s11469-020-00239-7
2.
BennettA. S.ScheidellJ.BowlesJ. M.KhanM.RothA.HoffL.MariniC.ElliottL. (2022). Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City. Harm Reduction Journal, 19(1), 20. Article 1. https://doi.org/10.1186/s12954-022-00604-w
3.
BohnertA. S. B.BradshawC. P.LatkinC. A. (2009). A social network perspective on heroin and cocaine use among adults: Evidence of bidirectional influences. Addiction, 104(7), 1210–1218. https://doi.org/10.1111/j.1360-0443.2009.02615.x
4.
Boileau-FalardeauM.ContrerasG.GaripyG.LapriseC. (2022). Patterns and motivations of polysubstance use: A rapid review of the qualitative evidence. Health promotion and chronic disease prevention in Canada: research. policy and practice, 42(2), 47.
5.
BresinK.MekawiY. (2021). The “why” of drinking matters: A meta-analysis of the association between drinking motives and drinking outcomes. Alcoholism: Clinical and Experimental Research, 45(1), 38–50. https://doi.org/10.1111/acer.14518
6.
BuntingA. M.OserC.StatonM.KnudsenH. (2020). Polysubstance use patterns among ustice-involved individuals who use opioids. Substance Use & Misuse, 55(13), 2165–2174. https://doi.org/10.1080/10826084.2020.1795683
7.
BuntingA. M.ShearerR.Linden-CarmichaelA. N.WilliamsA. R.ComerS. D.CerdáM.LorvickJ. (2023). Are you thinking what I’m thinking? Defining what we mean by “polysubstance use”. The American Journal of Drug and Alcohol Abuse, 50(1), 1–7. https://doi.org/10.1080/00952990.2023.2248360
8.
ChenK. W.BergerC. C.FordeD. P.D’AdamoC.WeintraubE.GandhiD. (2011). Benzodiazepine use and misuse among patients in a methadone program. BMC Psychiatry, 11, 90. https://doi.org/10.1186/1471-244X-11-90
9.
ChildsE.LutzJ. A.de WitH. (2017). Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. Drug and Alcohol Dependence, 177, 136–144. https://doi.org/10.1016/j.drugalcdep.2017.03.030
10.
ComptonW. M.ValentinoR. J.DuPontR. L. (2021). Polysubstance use in the U.S. opioid crisis. Molecular Psychiatry, 26(1), 41–50. Article 1. https://doi.org/10.1038/s41380-020-00949-3
11.
ConeE. J. (2012). Oral fluid results compared to self reports of recent cocaine and heroin use by methadone maintenance patients. Forensic Science International, 215(1-3), 88–91. https://doi.org/10.1016/j.forsciint.2011.01.046
12.
CooperM. L.KuntscheE.LevittA.BarberL. L.WolfS. (2016). Motivational models of substance use: A review of theory and research on motives for using alcohol, marijuana, and tobacco. In SherK. J. (Ed.), The oxford handbook of substance use and substance use disorders: Volume 1 (p. 17). Oxford University Press. https://doi.org/10.1093/oxfordhb/9780199381678.013.017
13.
CrumR. M.La FlairL.StorrC. L.GreenK. M.StuartE. A.AlvanzoA. A. H.LazareckS.BoltonJ. M.RobinsonJ.SareenJ.MojtabaiR. (2013). Reports of drinking to self-medicate anxiety symptoms: Longitudinal assessment for subgroups of individuals with alcohol dependence. Depression and Anxiety, 30(2), 174–183. https://doi.org/10.1002/da.22024
14.
CrummyE. A.O’NealT. J.BaskinB. M.FergusonS. M. (2020). One is not enough: Understanding and modeling polysubstance use. Frontiers in Neuroscience, 14, 569. https://doi.org/10.3389/fnins.2020.00569
15.
Dobler-MikolaA.HättenschwilerJ.MeiliD.BeckT.BöniE.ModestinJ. (2005). Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment. Journal of Substance Abuse Treatment, 29(4), 259–265. https://doi.org/10.1016/j.jsat.2005.08.002
16.
EllisM. S.KasperZ. A.CiceroT. J. (2018). Twin epidemics: The surging rise of methamphetamine use in chronic opioid users. Drug and Alcohol Dependence, 193, 14–20. https://doi.org/10.1016/j.drugalcdep.2018.08.029
17.
GiordanoA. L.ProsekE. A.StammanJ.CallahanM. M.LoseuS.BevlyC. M.CrossK.WoehlerE. S.CalzadaR.-M. R.ChadwellK. (2016). Addressing trauma in substance abuse treatment. Journal of Alcohol and Drug Education, 60(2), 55–71.
18.
HunaultC. C.BöckerK. B. E.StellatoR. K.KenemansJ. L.de VriesI.MeulenbeltJ. (2014). Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: A randomized, crossover clinical trial. Psychopharmacology, 231(24), 4723–4733. https://doi.org/10.1007/s00213-014-3630-2
19.
KaramouzianM.PilarinosA.HayashiK.BuxtonJ. A.KerrT. (2022). Latent patterns of polysubstance use among people who use opioids: A systematic review. International Journal of Drug Policy, 102, Article 103584. https://doi.org/10.1016/j.drugpo.2022.103584
20.
KearnsN. T.CloutierR. M.CareyC.ContractorA. A.BlumenthalH. (2019). Alcohol and marijuana polysubstance use: Comparison of PTSD symptom endorsement and severity patterns. Cannabis, 2(1), 39–52. Article 1. https://doi.org/10.26828/cannabis.2019.01.004
21.
KlineD.BuntingA. M.HeplerS. A.Rivera-AguirreA.KrawczykN.CerdaM. (2023). State-level history of overdose deaths involving stimulants in the United States, 1999‒2020. American Journal of Public Health, 113(9), 991–999. https://doi.org/10.2105/AJPH.2023.307337
22.
LeeC. M.CalhounB. H.AbdallahD. A.BlayneyJ. A.SchultzN. R.BrunnerM.PatrickM. E. (2022). Simultaneous alcohol and marijuana use among young adults: A scoping review of prevalence, patterns, psychosocial correlates, and consequences. Alcohol Research: Current Reviews, 42(1), 08. https://doi.org/10.35946/arcr.v42.1.08
LiuS.O'DonnellJ.GladdenR. M.McGloneL.ChowdhuryF. (2021). Trends in nonfatal and fatal overdoses involving benzodiazepines—38 states and the District of Columbia, 2019–2020. MMWR. Morbidity and Mortality Weekly Report, 70(34), 1136–1141. https://doi.org/10.15585/mmwr.mm7034a2
25.
LiuY.Guazzelli WilliamsonV.SetlowB.CottlerL. B.KnackstedtL. A. (2018). The importance of considering polysubstance use: Lessons from cocaine research. Drug and Alcohol Dependence, 192, 16–28. https://doi.org/10.1016/j.drugalcdep.2018.07.025
26.
López-CastroT.SohlerN.RibackL.BravoG.OhlendorfE.GhiroliM.FoxA. D. (2024). Posttraumatic stress disorder in people who use drugs: Syringe services program utilization, treatment need, and preferences for onsite mental health care. Harm Reduction Journal, 21(1), 108. https://doi.org/10.1186/s12954-024-01019-5
27.
MahuI. T.BarrettS. P.ConrodP. J.BartelS. J.StewartS. H. (2021). Different drugs come with different motives: Examining motives for substance use among people who engage in polysubstance use undergoing methadone maintenance therapy (MMT). Drug and Alcohol Dependence, 229(Pt B), Article 109133. https://doi.org/10.1016/j.drugalcdep.2021.109133
28.
MarianiJ. J.KhantzianE. J.LevinF. R. (2014). The self-medication hypothesis and psychostimulant treatment of cocaine dependence: An update. American Journal on Addictions/American Academy of Psychiatrists in Alcoholism and Addictions, 23(2), 189–193. https://doi.org/10.1111/j.1521-0391.2013.12086.x
29.
MartinottiG.CarliV.TedeschiD.Di GiannantonioM.RoyA.JaniriL.SarchiaponeM. (2009). Mono- and polysubstance dependent subjects differ on social factors, childhood trauma, personality, suicidal behaviour, and comorbid Axis I diagnoses. Addictive Behaviors, 34(9), 790–793. https://doi.org/10.1016/j.addbeh.2009.04.012
30.
MccabeS. E.CranfordJ. A.MoralesM.YoungA. (2006). Simultaneous and concurrent polydrug use of alcohol and prescription drugs: Prevalence, correlates, and consequences. Journal of Studies on Alcohol, 67(4), 529–537. https://doi.org/10.15288/jsa.2006.67.529
31.
McLellanA. T.KushnerH.MetzgerD.PetersR.SmithI.GrissomG.PettinatiH.ArgeriouM. (1992). The fifth edition of the addiction severity Index. Journal of Substance Abuse Treatment, 9(3), 199–213. https://doi.org/10.1016/0740-5472(92)90062-s
32.
McNeilR.PuriN.BoydJ.MayerS.HayashiK.SmallW. (2020). Understanding concurrent stimulant use among people on methadone: A qualitative study. Drug and alcohol review, 39(3), 209–215.
33.
MillsK. L.TeessonM.RossJ.PetersL. (2006). Trauma, PTSD, and substance use disorders: Findings from the Australian national survey of mental health and well-being. American Journal of Psychiatry, 163(4), 652–658. https://doi.org/10.1176/ajp.2006.163.4.652
34.
Motta-OchoaR.BertrandK.ArrudaN.Jutras-AswadD.RoyÉ. (2017). “I love having benzos after my coke shot”: The use of psychotropic medication among cocaine users in downtown Montreal. International Journal of Drug Policy, 49, 15–23. https://doi.org/10.1016/j.drugpo.2017.07.012
35.
NajavitsL. M.ClarkH. W.DiClementeC. C.PotenzaM. N.ShafferH. J.SorensenJ. L.TullM. T.ZwebenA.ZwebenJ. E. (2020). PTSD/Substance use disorder comorbidity: Treatment options and public health needs. Current Treatment Options in Psychiatry, 7(4), 544–558. https://doi.org/10.1007/s40501-020-00234-8
36.
NajavitsL. M.HienD. (2013). Helping vulnerable populations: A comprehensive review of the treatment outcome literature on substance use disorder and PTSD. Journal of Clinical Psychology, 69(5), 433–479. https://doi.org/10.1002/jclp.21980
37.
NeaigusA.GyarmathyV. A.MillerM.FrajzyngierV. M.FriedmanS. R.Des JarlaisD. C. (2006). Transitions to injecting drug use among noninjecting heroin users: Social network influence and individual susceptibility. JAIDS Journal of Acquired Immune Deficiency Syndromes, 41(4), 493–503. https://doi.org/10.1097/01.qai.0000186391.49205.3b
PalisH.GanW.XavierC.DesaiR.ScowM.SedgemoreK.GreinerL.NichollsT.SlaunwhiteA. (2022). Association of opioid and stimulant use disorder diagnoses with fatal and nonfatal overdose among people with a history of incarceration. JAMA Network Open, 5(11), Article e2243653. https://doi.org/10.1001/jamanetworkopen.2022.43653
43.
PrestonK. L.JobesM. L.PhillipsK. A.EpsteinD. H. (2016). Real-time assessment of alcohol drinking and drug use in opioid-dependent polydrug users. Behavioural Pharmacology, 27(7), 579–584. https://doi.org/10.1097/FBP.0000000000000250
RiggK. K.IbañezG. E. (2010). Motivations for non-medical prescription drug use: A mixed methods analysis. Journal of Substance Abuse Treatment, 39(3), 236–247. https://doi.org/10.1016/j.jsat.2010.06.004
46.
RosenquistJ. N.MurabitoJ.FowlerJ. H.ChristakisN. A. (2010). The spread of alcohol consumption behavior in a large social network. Annals of Internal Medicine, 152(7), 426. https://doi.org/10.7326/0003-4819-152-7-201004060-00007
47.
SalgadoD. M.QuinlanK. J.ZlotnickC. (2007). The relationship of lifetime polysubstance dependence to trauma exposure, symptomatology, and psychosocial functioning in incarcerated women with comorbid PTSD and substance use disorder. Journal of Trauma & Dissociation, 8(2), 9–26. https://doi.org/10.1300/J229v08n02_02
48.
SubbaramanM. S.KerrW. C. (2015). Simultaneous versus concurrent use of alcohol and cannabis in the national alcohol survey. Alcohol: Clinical and Experimental Research, 39(5), 872–879. https://doi.org/10.1111/acer.12698
49.
ToriM. E.LarochelleM. R.NaimiT. S. (2020). Alcohol or benzodiazepine Co-involvement with opioid overdose deaths in the United States, 1999-2017. JAMA Network Open, 3(4), Article e202361. https://doi.org/10.1001/jamanetworkopen.2020.2361
50.
TsuiJ. I.MayfieldJ.SpeakerE. C.YakupS.RiesR.FunaiH.LerouxB. G.MerrillJ. O. (2020). Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine. Journal of Substance Abuse Treatment, 109, 80–85. https://doi.org/10.1016/j.jsat.2019.10.005
51.
TuazonE.BaumanM.SunT.WeitzA.DeWaltJ.ManthaS.HarocoposA. (2023). Unintentional drug poisoning (overdose) deaths in New York city in 2022. (137; Epi Brief). New York City Department of Health and Mental Hygiene.
52.
Tuval-MashiachR. (2021). Is replication relevant for qualitative research?Qualitative Psychology, 8(3), 365–377. https://doi.org/10.1037/qup0000217
53.
UllmanS. E.TownsendS. M.StarzynskiL. L.LongL. M. (2006). Correlates of comorbid PTSD and polysubstance use in sexual assault victims. Violence and Victims, 21(6), 725–743. https://doi.org/10.1891/0886-6708.21.6.725
54.
ValenteP. K.BazziA. R.ChildsE.SalhaneyP.EarlywineJ.OlsonJ.BiancarelliD. L.MarshallB. D. L.BielloK. B. (2020). Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. Northeast. International Journal of Drug Policy, 85, Article 102934. https://doi.org/10.1016/j.drugpo.2020.102934
WhiteW. L.CampbellM. D.SpencerR. D.HoffmanH. A.CrissmanB.DuPontR. L. (2014). Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention. Journal of Psychoactive Drugs, 46(2), 114–122. https://doi.org/10.1080/02791072.2014.901587
57.
WilliamsonA.DarkeS.RossJ.TeessonM. (2006). The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence. Drug and Alcohol Dependence, 81(3), 293–300. https://doi.org/10.1016/j.drugalcdep.2005.08.010
